Literature DB >> 21633593

Management of liver cirrhosis between primary care and specialists.

Ignazio Grattagliano, Enzo Ubaldi, Leonilde Bonfrate, Piero Portincasa.   

Abstract

This article discusses a practical, evidence-based approach to the diagnosis and management of liver cirrhosis by focusing on etiology, severity, presence of complications, and potential home-managed treatments. Relevant literature from 1985 to 2010 (PubMed) was reviewed. The search criteria were peer-reviewed full papers published in English using the following MESH headings alone or in combination: "ascites", "liver fibrosis", "cirrhosis", "chronic hepatitis", "chronic liver disease", "decompensated cirrhosis", "hepatic encephalopathy", "hypertransaminasemia", "liver transplantation" and "portal hypertension". Forty-nine papers were selected based on the highest quality of evidence for each section and type (original, randomized controlled trial, guideline, and review article), with respect to specialist setting (Gastroenterology, Hepatology, and Internal Medicine) and primary care. Liver cirrhosis from any cause represents an emerging health issue due to the increasing prevalence of the disease and its complications worldwide. Primary care physicians play a key role in early identification of risk factors, in the management of patients for improving quality and length of life, and for preventing complications. Specialists, by contrast, should guide specific treatments, especially in the case of complications and for selecting patient candidates for liver transplantation. An integrated approach between specialists and primary care physicians is essential for providing better outcomes and appropriate home care for patients with liver cirrhosis.

Entities:  

Keywords:  Ascites; Family medicine; Hepatic encephalopathy; Hypertransaminasemia; Portal hypertension

Mesh:

Year:  2011        PMID: 21633593      PMCID: PMC3098395          DOI: 10.3748/wjg.v17.i18.2273

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  67 in total

1.  Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.

Authors:  Guadalupe Garcia-Tsao; Arun J Sanyal; Norman D Grace; William Carey
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

2.  American Gastroenterological Association medical position statement: osteoporosis in hepatic disorders.

Authors: 
Journal:  Gastroenterology       Date:  2003-09       Impact factor: 22.682

3.  Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis.

Authors:  Yasutoshi Muto; Shunichi Sato; Akiharu Watanabe; Hisataka Moriwaki; Kazuyuki Suzuki; Akinobu Kato; Masahiko Kato; Teiji Nakamura; Kiyohiro Higuchi; Shuhei Nishiguchi; Hiromitsu Kumada
Journal:  Clin Gastroenterol Hepatol       Date:  2005-07       Impact factor: 11.382

4.  Early use of TIPS in patients with cirrhosis and variceal bleeding.

Authors:  Juan Carlos García-Pagán; Karel Caca; Christophe Bureau; Wim Laleman; Beate Appenrodt; Angelo Luca; Juan G Abraldes; Frederik Nevens; Jean Pierre Vinel; Joachim Mössner; Jaime Bosch
Journal:  N Engl J Med       Date:  2010-06-24       Impact factor: 91.245

Review 5.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

6.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Authors:  Laurent Castéra; Julien Vergniol; Juliette Foucher; Brigitte Le Bail; Elise Chanteloup; Maud Haaser; Monique Darriet; Patrice Couzigou; Victor De Lédinghen
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

Review 7.  Pathophysiology, complications, and treatment of ascites.

Authors:  P Ginès; V Arroyo; J Rodès
Journal:  Clin Liver Dis       Date:  1997-05       Impact factor: 6.126

Review 8.  Managing nonalcoholic fatty liver disease: recommendations for family physicians.

Authors:  Ignazio Grattagliano; Piero Portincasa; Vincenzo O Palmieri; Giuseppe Palasciano
Journal:  Can Fam Physician       Date:  2007-05       Impact factor: 3.275

9.  Improving nonalcoholic fatty liver disease management by general practitioners: a critical evaluation and impact of an educational training program.

Authors:  Ignazio Grattagliano; Gaetano D'Ambrosio; Gaetano D'Ambrozio; Vincenzo O Palmieri; Antonio Moschetta; Giuseppe Palasciano; Piero Portincasa
Journal:  J Gastrointestin Liver Dis       Date:  2008-12       Impact factor: 2.008

Review 10.  Non-alcoholic fatty liver disease in the metabolic syndrome.

Authors:  Giuseppe Palasciano; Antonio Moschetta; Vincenzo O Palmieri; Ignazio Grattagliano; Gianluca Iacobellis; Piero Portincasa
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

View more
  17 in total

1.  Quantitative detection of cirrhosis: towards the development of computer-assisted detection method.

Authors:  Hannu T Huhdanpaa; Peng Zhang; Venkataramu N Krishnamurthy; Chris Douville; Binu Enchakolody; Chris Chou; Sampathkumar Ethiraj; Stewart Wang; Grace L Su
Journal:  J Digit Imaging       Date:  2014-10       Impact factor: 4.056

2.  Hepatocellular Carcinoma Surveillance in a Cohort of Chronic Hepatitis C Virus-Infected Patients with Cirrhosis.

Authors:  Winston E Abara; P Spradling; Y Zhong; A Moorman; E H Teshale; L Rupp; S C Gordon; M Schmidt; J A Boscarino; Y G Daida; S D Holmberg
Journal:  J Gastrointest Cancer       Date:  2020-06

3.  Evaluation of liver enzyme levels and identification of asymptomatic liver disease patients in primary care.

Authors:  Irene Cacciola; Riccardo Scoglio; Angela Alibrandi; Giovanni Squadrito; Giovanni Raimondo
Journal:  Intern Emerg Med       Date:  2016-09-19       Impact factor: 3.397

Review 4.  Quality of life in cirrhosis.

Authors:  Anthony Loria; Carey Escheik; N Lynn Gerber; Zobair M Younossi
Journal:  Curr Gastroenterol Rep       Date:  2013-01

5.  Hepatocellular carcinoma in patients with chronic kidney disease.

Authors:  Chern-Horng Lee; Sen-Yung Hsieh; Ja-Liang Lin; Maw-Sen Liu; Tzung-Hai Yen
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

6.  GPs' experiences and perceptions of early detection of liver disease: a qualitative study in primary care.

Authors:  Holly C Standing; Helen Jarvis; James Orr; Catherine Exley; Mark Hudson; Eileen Kaner; Barbara Hanratty
Journal:  Br J Gen Pract       Date:  2018-09-24       Impact factor: 5.386

7.  Consilience in sarcopenia of cirrhosis.

Authors:  Srinivasan Dasarathy
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-05-31       Impact factor: 12.910

8.  High Prevalence of Cirrhosis at Initial Presentation Among Safety-Net Adults with Chronic Hepatitis B Virus Infection.

Authors:  Elaine Tang; Sharon Torres; Benny Liu; Rachel Baden; Taft Bhuket; Robert J Wong
Journal:  J Clin Exp Hepatol       Date:  2017-11-27

9.  Risk of liver cancer among US male veterans with cirrhosis, 1969-1996.

Authors:  E C Persson; S M Quraishi; T M Welzel; J D Carreon; G Gridley; B I Graubard; K A McGlynn
Journal:  Br J Cancer       Date:  2012-05-15       Impact factor: 7.640

10.  A Complex Multiherbal Regimen Based on Ayurveda Medicine for the Management of Hepatic Cirrhosis Complicated by Ascites: Nonrandomized, Uncontrolled, Single Group, Open-Label Observational Clinical Study.

Authors:  Manish V Patel; Kalapi B Patel; Shivenarain Gupta; Andreas Michalsen; Elmar Stapelfeldt; Christian S Kessler
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-03       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.